Endoscopy Devices Market Growth On The Basis Of Type, Application, Region & Forecast To 2030: Grand

Author : Mrudula Karmarkar | Published On : 18 Jan 2024

San Francisco, 18 January 2024: The Report Endoscopy Devices Market Size, Share & Trends Analysis Report By Product (Endoscopes, Flexible Endoscopes), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

The global endoscopy devices market size is estimated to reach USD 90.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.5% from 2023 to 2030. The growing adoption of minimally invasive endoscopic procedures by medical professionals to examine the esophagus, colon, and stomach and its application to perform biopsies and sclerotherapy are some of the factors boosting the market growth. In addition, the increasing trend of adopting disposable endoscopes to reduce the chances of cross-contamination is also anticipated to fuel the growth of the market over the forecast years.

In 2022, based on product, the endoscopes segment held the highest revenue share of 36.9% of the market. Growing awareness and rising adoption rate of endoscopes across various diagnostic and therapeutic procedures are driving the market growth of endoscopes. In addition, endoscopes aid in the diagnosis of complex disease conditions such as cancer, GI disorders, urinary disorders, and lung disorders.

Based on end-use, the outpatient facilities segment dominated the market in 2022 owing to the growing preference for minimally invasive procedures to lower overall cost and reduce the number of days of hospital stays which in turn is anticipated to drive the growth of the segment. In addition, faster recovery time, and minimal discomfort due to the use of less invasive keyhole endoscopic procedures also accelerate the adoption of endoscopy devices in outpatient facilities.

In addition, favorable reimbursement policies and the high availability of government and private hospitals performing endoscopy procedures are some of the prominent factors anticipated to drive the segment growth. North Americadominated the market in terms of the revenue share of 41.5% in 2022. The highest revenue share of this region is attributed to the increasing adoption of advanced endoscopic devices and the high availability of modern healthcare facilities performing minimally invasive surgical procedures. In addition, growing functional gastrointestinal disorders and other chronic diseases such as cancer also are the major factors driving market growth in this region.

Furthermore, the COVID-19 pandemic has significantly impacted the market owing to the cancellation and postponement of elective procedures. Moreover, the fear of getting infected with the COVID-19 virus also reduced the number of surgical procedures which in turn led to the reduction of the endoscopy devices adoption in 2020. For instance, according to a study published in the Arab Journal of Gastroenterology in 2020, the number of endoscopy procedures decreased about 50% during the pandemic globally.

Request sample report of Endoscopy Devices Market@ https://www.grandviewresearch.com/industry-analysis/endoscopy-devices-market/request/rs1

The less invasive properties and affordable post and pre-procedure cost of endoscopy devices are the major factors anticipated to boost the market growth over the forecast period. Furthermore, a shift in the trend to use disposable endoscopic components to minimize the procedure cost as well as the chance of cross-contamination is also expected to accelerate market growth over the years.

Endoscopy Devices Market Report Highlights

  • The market is anticipated to be estimated at USD 90.2 billion by 2030 owing to the growing adoption of minimally invasive endoscopic procedures by medical professionals in comparison with open surgeries
  • In terms of product, the endoscopes segment dominated the market in 2022 with the largest revenue share of 36.9% owing to the growing adoption of endoscopes for both diagnostic and therapeutic purposes coupled with the rising prevalence of chronic diseases
  • In terms of end-use, the outpatient facilities held the largest revenue share of 52.9% in 2022, owing to the availability of minimally invasive surgeries and shorter hospitalization stays.
  • Based on region, North America held the largest revenue share of 41.5% in 2022, owing to the increasing adoption of advanced endoscopy devices and the high availability of modern healthcare facilities performing minimally invasive surgical procedures

In addition, the growing chronic disease burden and increasing geriatric population globally are also anticipated to fuel the adoption of endoscopic devices during the coming years. Moreover, growing medical conditions due to the increasing geriatric population often require endoscopic intervention such as liver abscesses, gallstones, endometriosis, and intestinal perforation, which in turn anticipated to drive the market growth for endoscopy devices over the forecast years. For instance, as per the Administration on Aging (AoA) of the U.S. Department of Health and Human Services report, about 16% of the population was aged above 65 years in 2023. This number is expected to increase to 21.6% by 2040.

In addition, increasing preference by medical professionals to use technologically advanced endoscopy devices equipped with high-definition camera and light sources to help physicians analyze internal organs of interest also drives the market growth. The shift of preference towards minimally invasive surgical procedures than traditional surgeries to reduce hospital stay and minimize post-procedure complications are the major factors anticipated to fuel the demand for endoscopy devices. Hence, factors such as higher patient satisfaction, increased economic viability, and lesser hospital stays are expected to increase the demand for minimally invasive endoscopic interventions in the coming years, thereby accelerating market growth.

Furthermore, the growing burden of cancer all over the world also fuels the adoption of endoscopy devices for the early diagnosis and treatment of the disease. For instance, GLOBOCAN 2020 estimated 19.3 million new cancer cases worldwide and almost 10 million deaths occurred in 2020 due to cancer. In addition, the increasing preference for biopsies for diagnosis and detection of cancer in recent years is also likely to increase the adoption of endoscopic devices, which in turn is anticipated to drive the market for endoscopy devices over the years.

Endoscopy Devices Market Report Scope 

Report Attribute

Details

Market size value in 2023

USD 54.4 billion

Revenue forecast in 2030

USD 90.2 billion

Growth rate

CAGR of 7.5% from 2023 to 2030

Base year for estimation

2022

Historical data

2016 - 2021

Forecast period

2023 - 2030

Technological advancement to develop innovative endoscopic devices is also anticipated to accelerate market growth during forecast periods. The key manufacturers are continuously looking forward to innovating advanced endoscopic solutions for better treatment and diagnosis of several chronic disorders. For instance, in August 2021, Fujifilm Holdings Corporation announced the commercial launch of the ELUXEO 7000X Endoscopic Imaging System. This advanced imaging system enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue during laparoscopic and/or endoluminal imaging procedures.

The high demand for technologically advanced endoscopic products for diagnosis and treatment of several chronic disorders makes the competition intense among the existing players. In addition, the growing preference for the minimally invasive procedure with low costs, more safety, and reduced risks of contaminating the devices further increase the competition. Moreover, the top market players are also adopting business strategies such as new product launches, collaboration, mergers and acquisitions to increase their product portfolio and market share in the area of endoscopic devices. For instance, in September 2020, PENTAX Medical announced to launch new Ultrasound Video Gastroscopes J10 Series in the U.S. These advanced gastroscopes enable better image quality, increase diagnostic capabilities, and help in effective disease management of the patient.

List of Key Players in the Endoscopy Devices Market

  • Olympus Corporation
  • Ethicon Endo-surgery, LLC.
  • FUJIFILM Holdings Corporation
  • Stryker Corporation
  • Boston Scientific Corporation
  • Karl Storz GmbH & Co. KG
  • Smith & Nephew Inc.
  • Richard Wolf GmbH
  • Medtronic Plc (Covidien)
  • PENTAX Medical
  • Machida Endoscope Co., Ltd.